Let us help you customize your experience.
Tell us a little about yourself so we can share more relevant content and resources.
We're here for you and your family at our pediatric hospitals and care clinics – and at home.
Arkansas Children’s is home to the only fellowship-trained pediatric surgeons in the state. They are specially-trained in less invasive surgeries and understand that kids heal differently than adults. Everything we do is tailored to the unique needs of children: from newborns to young adults.
Arkansas Children's Hospital is making sure that all children who visit its campus for care have access to a free, nutritious meal as part of U.S. Department of Agriculture’s Summer Feeding program.
An NIH grant awarded to Arkansas Children’s Research Institute will help scientists at Arkansas Children’s and UAMS reduce life-threatening asthma attacks in children.
Arkansas Children’s joins a first-in-kind coalition bringing together some of the nation’s top children’s hospitals, in collaboration with Phlow, to provide certainty in availability and access for key medicines necessary to sustain life and conquer disease.
This is a research study to determine the effectiveness and safety profile of VIGIL in combination with standard relapsed chemotherapy for children and young adults with first relapse of Ewing’s Sarcoma.
A prospective open label, multicenter study to evaluate the feasibility and side effects of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.
The purpose of this study is to evaluate the pharmacokinetics (PK) of the research study drug, tedizolid phosphate (TZD), also known as SIVEXTRO, and its active metabolite tedizolid in subjects with known or suspected gram positive infection, and test the safety and tolerability of intravenous (IV) or oral TZD administration in pediatric subjects.
The COVID-19 vaccine is now available to teens in Arkansas 16 years and older. Dr. Jessica Snowden, chief of pediatric infectious disease at Arkansas Children’s was interviewed by KATV and addressed questions about the safety of the vaccine for the youth population.
Arkansas Children's reviews the signs of a concussion in children and young athletes.
We know that healthcare can be complicated, so we make it as easy as possible to access primary and specialty care.